Dirk M. Nettelbeck

4.3k citations

83 papers · 3.4k indexed · h-index 36

Molecular Biology top 5%
Genetics top 0.5%
Oncology top 2%
Immunology top 5%
Biotechnology top 1%

Co-authors: Rolf Müller David T. Curiel Valérie Jérôme Johanna K. Kaufmann Roland E. Kontermann Ángel A. Rivera Akseli Hemminki Guy Ungerechts
Topics: Virus-based gene therapy research (63 papers)CAR-T cell therapy research (40 papers)Viral Infectious Diseases and Gene Expression in Insects (32 papers)
Cited by: Genetics Oncology Biotechnology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research The Journal of Immunology
Partner nations: Germany United States France

In The Last Decade

Dirk M. Nettelbeck

82 papers receiving 3.4k citations

Peers

Countries citing papers authored by Dirk M. Nettelbeck

Since Specialization

Citations

This map shows the geographic impact of Dirk M. Nettelbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk M. Nettelbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk M. Nettelbeck more than expected).

Fields of papers citing papers by Dirk M. Nettelbeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk M. Nettelbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk M. Nettelbeck. The network helps show where Dirk M. Nettelbeck may publish in the future.

Co-authorship network of co-authors of Dirk M. Nettelbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk M. Nettelbeck. A scholar is included among the top collaborators of Dirk M. Nettelbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk M. Nettelbeck. Dirk M. Nettelbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene Therapy “Made in Germany”: A Historical Perspective, Analysis of the Status Quo, and Recommendations for Action by the German Society for Gene Therapy 2021 ·Human Gene Therapy ·Hildegard Büning,Boris Fehse,Zoltán Ivics,Stefan Kochanek,Ulrike Koehl,Christian Kupatt,Claudio Mussolino,Dirk M. Nettelbeck,Axel Schambach,Wolfgang Uckert,Ernst Wagner,Toni Cathomen,(unknown)	2
2	Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach 2018 ·Cancer Immunology Immunotherapy ·Angela M. Krackhardt,Brigitte Anliker,Martin Hildebrandt,Michael Bachmann,Stefan B. Eichmüller,Dirk M. Nettelbeck,Matthias Renner,Lutz Uharek,Gerald Willimsky,Michael Schmitt,Winfried S. Wels,Martina Schüßler‐Lenz	12
3	Virotherapy Research in Germany: From Engineering to Translation 2017 ·Human Gene Therapy ·Guy Ungerechts,Christine E. Engeland,Christian J. Buchholz,Jürgen Eberle,Henry Fechner,Karsten Geletneky,Per Sonne Holm,Florian Kreppel,Florian Kühnel,Karl S. Lang,Mathias F. Leber,Antonio Marchini,Markus Moehler,Michael D. Mühlebach,Jean Rommelaere,Christoph Springfeld,Ulrich M. Lauer,Dirk M. Nettelbeck	20
4	Artificial riboswitches for gene expression and replication control of DNA and RNA viruses 2014 ·Proceedings of the National Academy of Sciences ·Patrick Ketzer,Johanna K. Kaufmann,(unknown),Sascha Bossow,Christof von Kalle,Jörg S. Hartig,Guy Ungerechts,Dirk M. Nettelbeck	90
5	CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy 2014 ·Molecular Therapy ·Christine E. Engeland,Christian Grossardt,Rūta Veinalde,Sascha Bossow,(unknown),Johanna K. Kaufmann,Ivan Shevchenko,Viktor Umansky,Dirk M. Nettelbeck,Wilko Weichert,Dirk Jäger,Christof von Kalle,Guy Ungerechts	239
6	Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies 2011 ·International Journal of Hyperthermia ·Ilka Knippertz,(unknown),Jan Dörrie,Niels Schaft,Ina Müller,(unknown),Alexander Steinkasserer,Dirk M. Nettelbeck	68
7	Human dendritic cells efficiently phagocytose adenoviral oncolysate but require additional stimulation to mature 2011 ·International Journal of Cancer ·(unknown),Andrea Hesse,Ilka Knippertz,Eckhart Kaempgen,Andreas S. Baur,Gerold Schuler,Alexander Steinkasserer,Dirk M. Nettelbeck	5
8	An in-vitro tumour microenvironment model using adhesion to type I collagen reveals Akt-dependent radiation resistance in renal cancer cells 2009 ·Nephrology Dialysis Transplantation ·(unknown),(unknown),(unknown),Raphael Gorodetsky,Shimon Lecht,Dirk M. Nettelbeck,Yosef S. Haviv	16
9	Transgene expression by oncolytic adenoviruses is modulated by E1B19K deletion in a cell type-dependent manner 2009 ·Virology ·(unknown),(unknown),Andrea Hesse,(unknown),Wibke Bayer,Christel Herold‐Mende,Yosef S. Haviv,Oliver Wildner,Alexander Enk,Dirk M. Nettelbeck	9
10	Human melanoma cells expressing the αvβ3 integrin are partially protected from necrotic cell death induced by dynamic matrix detachment 2009 ·Cancer Letters ·(unknown),(unknown),(unknown),Simcha Urieli-Shoval,Raphael Gorodetsky,Idit Avrahami,Dirk M. Nettelbeck,Yosef S. Haviv	4
11	Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis 2009 ·Advanced Drug Delivery Reviews ·(unknown),Dirk M. Nettelbeck	121
12	A novel dynamic matrix detachment model reveals a shift from apoptosis to necrosis in melanoma cells 2008 ·Cancer Letters ·(unknown),(unknown),Idit Avrahami,(unknown),(unknown),(unknown),Dirk M. Nettelbeck,Yosef S. Haviv	6
13	Combining adenoviral oncolysis with temozolomide improves cell killing of melanoma cells 2007 ·International Journal of Cancer ·(unknown),Astrid Mainka,Andrea Hesse,Dirk M. Nettelbeck	30
14	Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures 2004 ·Molecular Cancer Therapeutics ·N. Sanjib Banerjee,Ángel A. Rivera,Minghui Wang,Louise T. Chow,Thomas R. Broker,David T. Curiel,Dirk M. Nettelbeck	46
15	Transcriptional targeting of tumors with a novel tumor-specific survivin promoter 2004 ·Cancer Gene Therapy ·Zeng B. Zhu,Sharmila Makhija,Baogen Lu,Minghui Wang,(unknown),Bin Liu,Ángel A. Rivera,Dirk M. Nettelbeck,Parameshwar J. Mahasreshti,Charles A. Leath,Shannon Barker,(unknown),Fengzhi Li,Ronald D. Alvarez,David T. Curiel	86
16	Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo 2004 ·Virology ·Ángel A. Rivera,Minghui Wang,Kaori Suzuki,Taco G. Uil,Victor Krasnykh,David T. Curiel,Dirk M. Nettelbeck	49
17	Enhanced Adenovirus Infection of Melanoma Cells by Fiber-Modification: Incorporation of RGD Peptide or Ad5/3 Chimerism 2003 ·Cancer Biology & Therapy ·Andrea L. Volk,Ángel A. Rivera,Anna Kanerva,Gerd Bauerschmitz,Igor P. Dmitriev,Dirk M. Nettelbeck,David T. Curiel	59
18	Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma 2003 ·Melanoma Research ·Dirk M. Nettelbeck,(unknown),Julia Davydova,Detlef Dieckmann,Masato Yamamoto,DT Curiel	19
19	Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells 1998 ·International Journal of Cancer ·Sabine Brüsselbach,Dirk M. Nettelbeck,(unknown),Rolf Müller	81
20	A strategy for enhancing the transcriptional activity of weak cell type-specific promoters 1998 ·Gene Therapy ·Dirk M. Nettelbeck,Valérie Jérôme,Rolf Müller	58

About Dirk M. Nettelbeck

Dirk M. Nettelbeck is a scholar working on Genetics, Oncology and Biotechnology, having authored 83 papers that have together received 3.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (63 papers), CAR-T cell therapy research (40 papers) and Viral Infectious Diseases and Gene Expression in Insects (32 papers). The work is most often cited by research in Genetics (2.2k citations), Oncology (1.6k citations) and Biotechnology (458 citations). Dirk M. Nettelbeck has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Rolf Müller, David T. Curiel, Valérie Jérôme, Johanna K. Kaufmann, Roland E. Kontermann, Ángel A. Rivera, Akseli Hemminki, Guy Ungerechts, Ronald D. Alvarez and Sascha Bossow. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact